LIPOPROTEIN(A), APOLIPOPROTEIN(A) POLYMORPHISM, AND INSULIN-TREATMENT IN TYPE-II DIABETIC-PATIENTS

被引:10
|
作者
BUSCAGLIA, P
GAZZARUSO, C
GARZANITI, A
BONETTI, G
FRATINO, P
GEROLDI, D
机构
[1] POLICLIN SAN MATTEO,IRCCS,DEPT INTERNAL MED & MED THERAPEUT,MED CLIN 1,I-27100 PAVIA,ITALY
[2] UNIV PAVIA,POLO UNIV CITTA PAVIA,DEPT INTERNAL MED & MED THERAPEUT,I-27100 PAVIA,ITALY
关键词
D O I
10.2337/diacare.18.8.1202
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1202 / 1203
页数:2
相关论文
共 50 条
  • [41] THE EFFECT OF INSULIN-TREATMENT ON INSULIN-SECRETION AND ACTION IN TYPE-II DIABETES (NIDDM)
    GARVEY, T
    GRIFFIN, J
    REVERS, R
    OLEFSKY, J
    KOLTERMAN, O
    CLINICAL RESEARCH, 1983, 31 (02): : A386 - A386
  • [42] THE EFFECT OF INSULIN-TREATMENT ON INSULIN-SECRETION AND ACTION IN TYPE-II DIABETES (NIDDM)
    GARVEY, T
    GRIFFIN, J
    REVERS, R
    OLEFSKY, J
    KOLTERMAN, O
    CLINICAL RESEARCH, 1983, 31 (01): : A93 - A93
  • [43] TRANSDERMAL INSULIN APPLICATION IN TYPE-II DIABETIC-PATIENTS - RESULTS OF A CLINICAL PILOT-STUDY
    LIEDTKE, RK
    SORGER, M
    MERK, F
    VETTER, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-2 (08): : 884 - 886
  • [44] EFFECTS OF BENFLUOREX ON INSULIN RESISTANCE AND LIPID-METABOLISM IN OBESE TYPE-II DIABETIC-PATIENTS
    BIANCHI, R
    BONGERS, V
    BRAVENBOER, B
    ERKELENS, DW
    DIABETES CARE, 1993, 16 (04) : 557 - 559
  • [45] EXOGENOUS INSULIN RETARDS RATE OF WEIGHT-LOSS IN OBESE TYPE-II DIABETIC-PATIENTS
    HARRIS, MD
    DAVIDSON, MB
    BUSH, MA
    INTERNATIONAL JOURNAL OF OBESITY, 1985, 9 (04) : A40 - A40
  • [46] ROLE OF GLUCOSE AND INSULIN ON CALCIUM HANDLING IN TYPE-II DIABETIC-PATIENTS WITH AND WITHOUT HYPERTENSION AND MICROALBUMINURIA
    SOLINI, A
    DIVIRGILIO, F
    TREVISAN, M
    CIPOLLINA, MR
    NOSADINI, R
    CREPALDI, G
    DIABETOLOGIA, 1994, 37 : A46 - A46
  • [47] EXOGENOUS INSULIN RETARDS RATE OF WEIGHT-LOSS IN OBESE TYPE-II DIABETIC-PATIENTS
    HARRIS, MD
    DAVIDSON, MB
    BUSH, MA
    CLINICAL RESEARCH, 1986, 34 (01): : A59 - A59
  • [48] COMPARISON BETWEEN ACARBOSE, METFORMIN, AND INSULIN-TREATMENT IN TYPE-2 DIABETIC-PATIENTS WITH SECONDARY FAILURE TO SULFONYLUREA TREATMENT
    CALLEPASCUAL, AL
    GARCIAHONDUVILLA, J
    MARTINALVAREZ, PJ
    VARA, E
    CALLE, JR
    MUNGUIRA, ME
    MARANES, JP
    DIABETES & METABOLISM, 1995, 21 (04) : 256 - 260
  • [49] INVOLVEMENT OF PROSTAGLANDINS IN THE ACTION OF CAPTOPRIL IN TYPE-II DIABETIC-PATIENTS
    KOEV, D
    ZACHARIEVA, S
    ANDONOVA, K
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1989, 93 (01): : 11 - 18
  • [50] PLASMA MEVALONATE AND CHOLESTEROGENESIS IN NORMOLIPIDEMIC TYPE-II DIABETIC-PATIENTS
    SCOPPOLA, A
    FRONTONI, S
    CASELLI, A
    TESTA, G
    LALA, A
    DIABETOLOGIA, 1995, 38 : A248 - A248